+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Stents Market by Type (Coronary Stents, Peripheral Vascular Stents, Prostatic Stents), Material (Biomaterials, Metallic Stents), Mode of Delivery, End-User - Forecast 2023-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337801
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Stents Market size was estimated at USD 12.10 billion in 2022, USD 12.99 billion in 2023, and is expected to grow at a CAGR of 7.49% to reach USD 21.57 billion by 2030.

Stents are inserted into blocked passageways to open passages in the heart, such as weak or narrowed arteries providing oxygen-rich blood. Stents are made of either plastic or metal and are coated with drugs to help prevent blocked arteries from closing. Stenting technology is increasingly preferred over conventional balloon angioplasty due to the introduction of advanced DES and evolving bioresorbable scaffolds. The rising incidence of cardiovascular diseases, the expanding elderly population, and the increasing preference for minimally invasive procedures have created a need for the utilization of stents. However, the surging incidence of recalls of stent systems and the risk associated with the stents may adversely impact the market's growth. Moreover, introducing new stent designs and product approvals from regulatory authorities are expected to increase the adoption of stents by healthcare facilities.

Regional Insights

The stent market in the Americas is advanced, driven by the presence of well-established and recognized manufacturers serving a diverse portfolio of stents and constantly upgrading their R&D to keep up with medical requirements. In the past few years, the U.S. Food & Drug Administration has provided multiple approvals for drug-eluting and cardiac stents, supporting further stent innovation in the region. The Asia-Pacific region is a mass provider of raw materials to Western nations and is occupied by trusted stent producers across India, China, and Japan. The country observes an improved reimbursement structure for heart surgeries and stent usage, and governments are working toward offering cost-effective stents to healthcare facilities. Europe has a more standardized stent market characterized by safety initiatives and research activities focused on introducing biodegradable stents. The Middle East region witnesses an exponential increase in investments in healthcare infrastructure advancements, creating the region a potential base for company expansion for market players.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Stents Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stents Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Andramed GmbH, Arterius Limited, B. Braun SE, Balton Sp. z o. o., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Elixir Medical Corporation, Eurocor Tech GmbH, Integer Holdings Corporation, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Mitra Industries Pvt. Ltd., Nano Therapeutics Pvt. Ltd., QMD, REVA Medical, LLC, Rontis AG, Scitech Medical Products SA, SLTL Group, Stryker Corporation, Terumo Corporation, Veryan Medical Ltd., and W. L. Gore & Associates, Inc.

Market Segmentation & Coverage

This research report categorizes the Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Coronary Stents
      • Bare-metal Stents
      • Drug-eluting Stents
    • Peripheral Vascular Stents
    • Prostatic Stents
    • Stent Grafts
    • Urinary Stents
  • Material
    • Biomaterials
    • Metallic Stents
      • Cobalt-Chromium
      • Nickel Titanium
      • Platinum Chromium
      • Stainless Steel
  • Mode of Delivery
    • Balloon-expandable Stents
    • Self-expanding Stents
  • End-User
    • Ambulatory Surgical Centers
    • Cardiac Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Stents Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stents Market?
  3. What are the technology trends and regulatory frameworks in the Stents Market?
  4. What is the market share of the leading vendors in the Stents Market?
  5. Which modes and strategic moves are suitable for entering the Stents Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Stents Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cardiovascular diseases and need for improved-quality stents
5.1.1.2. Growing inclination toward minimally invasive surgeries
5.1.1.3. Surging preference for biodegradable and bioabsorbable stents
5.1.2. Restraints
5.1.2.1. Surging incidence of recalls of stent systems
5.1.3. Opportunities
5.1.3.1. Emerging innovations in stent designs for high accuracy and reliability
5.1.3.2. The surge in product approvals from regulatory authorities
5.1.4. Challenges
5.1.4.1. Risks of the utilization of stents and associated health consequences
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Surging government approvals coupled with increased availability of stents in emerging countries of the Americas
5.3.2. High provision of raw materials and improved government assistance to reduce stent prices in Asia
5.3.3. Enhanced reimbursement policies in Europe and favorable manufacturing facility expansion in the Middle East & Africa
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Stents Market, by Type
6.1. Introduction
6.2. Coronary Stents
6.3.1. Bare-metal Stents
6.3.2. Drug-eluting Stents
6.3. Peripheral Vascular Stents
6.4. Prostatic Stents
6.5. Stent Grafts
6.6. Urinary Stents
7. Stents Market, by Material
7.1. Introduction
7.2. Biomaterials
7.3. Metallic Stents
7.4.1. Cobalt-Chromium
7.4.2. Nickel Titanium
7.4.3. Platinum Chromium
7.4.4. Stainless Steel
8. Stents Market, by Mode of Delivery
8.1. Introduction
8.2. Balloon-expandable Stents
8.3. Self-expanding Stents
9. Stents Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Cardiac Centers
9.4. Hospitals
10. Americas Stents Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Stents Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Stents Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd.
13.3.1.2. Medtech giant Cordis acquires MedAlliance in a USD 1.1 billion deal.
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Getinge partners with Medtronic for the manufacturing of the Radiant[TM] balloon-expandable covered stent.
13.3.2.2. Micro-Tech Endoscopy Announces Distribution Partnership with Thoracent to Bring Leading Tracheal Y-Stent System to the U.S. Market.
13.3.3. New Product Launch & Enhancement
13.3.3.1. Medtronic launches the latest generation drug-eluting coronary stent system following CE Mark approval.
13.3.3.2. Abbott launches Xience Skypoint drug-eluting stent in extended sizes.
13.3.4. Investment & Funding
13.3.4.1. San Diego’s Reva Medical raises USD 45 M to develop naturally absorbable stents for lower legs.
13.3.4.2. FDA-Approved FFRangio from CathWorks Receives USD 75 Million Investment from Medtronic with an Option for Eventual Acquisition for Over a Half a Billion.
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Medtronic receives CE mark for the first balloon-expandable covered stent indicated for ChEVAR.
13.3.5.2. Biosensors International Wins FDA Approval For Drug-Eluting Coronary Stent.
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Alvimedica
14.1.3. Andramed GmbH
14.1.4. Arterius Limited
14.1.5. B. Braun SE
14.1.6. Balton Sp. z o. o.
14.1.7. Becton, Dickinson and Company
14.1.8. BIOTRONIK SE & Co. KG
14.1.9. Boston Scientific Corporation
14.1.10. Cardinal Health Inc.
14.1.11. Cook Medical LLC
14.1.12. Elixir Medical Corporation
14.1.13. Eurocor Tech GmbH
14.1.14. Integer Holdings Corporation
14.1.15. KYOTO MEDICAL PLANNING Co., Ltd.
14.1.16. Lepu Medical Technology(Beijing)Co., Ltd.
14.1.17. Medtronic PLC
14.1.18. Meril Life Sciences Pvt. Ltd.
14.1.19. MicroPort Scientific Corporation
14.1.20. Mitra Industries Pvt. Ltd.
14.1.21. Nano Therapeutics Pvt. Ltd.
14.1.22. QMD
14.1.23. REVA Medical, LLC
14.1.24. Rontis AG
14.1.25. Scitech Medical Products SA
14.1.26. SLTL Group
14.1.27. Stryker Corporation
14.1.28. Terumo Corporation
14.1.29. Veryan Medical Ltd.
14.1.30. W. L. Gore & Associates, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. STENTS MARKET RESEARCH PROCESS
FIGURE 2. STENTS MARKET SIZE, 2022 VS 2030
FIGURE 3. STENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. STENTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. STENTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. STENTS MARKET DYNAMICS
FIGURE 7. STENTS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. STENTS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. STENTS MARKET SIZE, BY MATERIAL, 2022 VS 2030 (%)
FIGURE 10. STENTS MARKET SIZE, BY MATERIAL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. STENTS MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2030 (%)
FIGURE 12. STENTS MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. STENTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. STENTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS STENTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS STENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES STENTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES STENTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC STENTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC STENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. STENTS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. STENTS MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • Abbott Laboratories
  • Alvimedica
  • Andramed GmbH
  • Arterius Limited
  • B. Braun SE
  • Balton Sp. z o. o.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Elixir Medical Corporation
  • Eurocor Tech GmbH
  • Integer Holdings Corporation
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Mitra Industries Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • QMD
  • REVA Medical, LLC
  • Rontis AG
  • Scitech Medical Products SA
  • SLTL Group
  • Stryker Corporation
  • Terumo Corporation
  • Veryan Medical Ltd.
  • W. L. Gore & Associates, Inc.

Methodology

Loading
LOADING...

Table Information